Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIG Regulatory News (SHI)

Share Price Information for SIG (SHI)

Share Price is delayed by 15 minutes
Get Live Data
8.04    -0.11 (-1.35%)
Bid:
7.74
Ask:
8.10
Spread: 0.36 (4.651%)
Market Cap: £92.92m
SHI Live PriceLast checked at - London Stock Exchange

Intraday SIG Share Chart

AGM Trading Update

10 May 2018 07:00

RNS Number : 5849N
SIG PLC
10 May 2018
Β 

Β 

10 May 2018

Β 

SIG plc: AGM Trading Update

Board expectations for 2018 remain unchanged

Β 

SIG plc ("SIG" or "the Group"), a leading European supplier of specialist building products with strong positions in its core markets of Insulation & Interiors, Roofing & Exteriors, and Air Handling, today issues a trading update for 1 January to 30 April 2018 (the "period"), in advance of its Annual General Meeting which is being held at 12 noon today in Sheffield.

Β 

Trading summary

Group revenues from continuing operations over the period increased by 2.2%, with currency contributing 2.0% to growth and working days 0.5%.

Β 

Β 

Β 

January to April 2018

January to April

2017

SIG Distribution

(2.2)%

+0.7%

SIG Exteriors

(10.6)%

+0.8%

Ireland & Other UK

+4.1%

+5.2%

UK & Ireland

(4.4)%

+1.0%

Β 

Β 

Β 

France

+1.4%

+3.1%

Germany

+5.0%

(0.9)%

Poland

+15.6%

+4.8%

Air Handling

(0.5)%

+11.7%

Benelux

+5.4%

(6.7)%

Mainland Europe

+3.8%

+2.0%

Β 

Β 

Β 

Group

(0.3)%

+1.5%

Β 

Β 

LFL revenues were down by 4.4% in the UK & Ireland, with a significant adverse impact from poor weather conditions in the region during February and March. The Exteriors business further suffered from weak market conditions in UK commercial new build and RMI markets, as previously indicated.

Β 

The Group's businesses across Mainland Europe continued to perform well, with LFL revenues up by 3.8% during the period. Whilst construction activity in France has been affected by the recent increase in industrial action, and LFL sales in the Group's Air Handling business are dependent on the phasing of project revenues during the year, growth has remained strong across Germany, the Benelux and particularly Poland.

Β 

Leverage

Leverage reduction remains a key medium term priority and the Group continues to focus on structural reductions in levels of working capital and sustained profit improvement to drive leverage lower. Seasonal fluctuations mean that debt and leverage are likely to remain similar to year end levels in the first half, but the Group remains on course to deliver leverage in a 1.0 - 1.5x range during 2018, with the Group continuing to target leverage below 1.0x over the medium term.

Β 

Outlook

Trading conditions remain mixed across the Group's markets, with continued confidence across Mainland Europe and Ireland but ongoing challenges in parts of the UK construction sector.

Β 

We continue to progress our plans to deliver a significant improvement in our operational and underlying financial performance, as well as focusing the portfolio and reducing leverage. We expect a stronger second half to the year, reflecting both normal seasonality and the benefit of ongoing cost and margin actions coming through in H2. Providing there is no further deterioration in UK market conditions, our expectations for underlying profitability for the full year remain unchanged.

Β 

- Ends -

Β 

1 Like-for-like is defined as sales per day in constant currency excluding acquisitions and disposals.

Β 

Enquiries

Β 

SIG plc

Meinie Oldersma, Chief Executive Officer +44 (0) 114 285 6300

Nick Maddock, Chief Financial Officer +44 (0) 114 285 6300

Hilary Kendrick, Group Communications Director +44 (0) 114 285 6300

Β 

FTI Consulting

Richard Mountain +44 (0) 20 3727 1340

Β 

Jefferies Hoare Govett

Chris Dickinson / Paul Nicholls +44 (0) 20 7029 8000

Β 

Peel Hunt LLP

Justin Jones / Charles Batten +44 (0) 20 7418 8900

Β 

Β 

Β 

Cautionary Statement

This Trading Statement is prepared for and addressed only to the Company's shareholders as a whole and to no other person. The Company, its directors, employees, agents or advisors do not accept or assume responsibility to any other person to whom this Trading Statement is shown or into whose hands it may come and any such responsibility or liability is expressly disclaimed.

Β 

Certain information included in this Trading Statement is forward looking and involves risks and uncertainties that could cause the actual results to differ materially from those expressed or implied by forward looking statements. It is believed that the expectations set out in these forward looking statements are reasonable but they may be affected by a wide range of variables which could cause future outcomes to differ from those foreseen in forward looking statements, including but not limited to, changes in risks associated with the level of market demand, product availability and pricing, competitor risk, credit risk, credit insurance, restructuring of SIG and exchange rates. More information about the risks and uncertainties that may affect the Group's performance is contained in the Annual Report to Shareholders for the year ended 31 December 2017. All statements in this release are based upon information known to the Company at the date of this Trading Statement. The Company undertakes no obligation to publicly update or revise any forward looking statement, whether as a result of new information, future events or otherwise.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTBCGDUDSGBGIC
Date   Source Headline
3rd Jun 20263:50 pmRNSDirector/PDMR Shareholding
28th May 20262:56 pmRNSDirector/PDMR Shareholding
22nd May 20261:36 pmRNSDirector/PDMR Shareholding
22nd May 20261:29 pmRNSDirector/PDMR Shareholding
22nd May 20261:18 pmRNSResult of Meeting
20th May 20263:07 pmRNSDirector/PDMR Shareholding
14th May 20264:44 pmRNSDirector/PDMR Shareholding
13th May 20265:27 pmRNSDirector/PDMR Shareholding
6th May 202611:11 amRNSDirector/PDMR Shareholding
6th May 202610:24 amRNSNotice of GM
30th Apr 20262:00 pmRNSResult of AGM
30th Apr 20267:01 amRNSTrading Update
30th Apr 20267:00 amRNSAppointment of Chief Financial Officer
10th Apr 20267:00 amRNSDirectorate change
23rd Mar 202610:57 amRNSDirector/PDMR Shareholding
23rd Mar 20269:59 amRNSNotice of AGM
4th Mar 202610:18 amRNSAnnual Financial Report
4th Mar 20267:00 amRNSFull year results for year ended 31 December 2025
15th Jan 20264:02 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNS2025 Full Year Trading Update & Strategy Framework
19th Dec 20257:00 amRNSNotice of Trading & Business Update
19th Dec 20257:00 amRNSNotice of Trading & Business Update
23rd Oct 202511:05 amRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSQ3 Trading Update
1st Oct 20259:00 amRNSDirector/PDMR Shareholding
3rd Sep 202510:54 amRNSHolding(s) in Company
28th Aug 20251:02 pmRNSResult of Meeting
8th Aug 202511:01 amRNSNotice of GM
5th Aug 20257:00 amRNSResults for the six months to 30 June 2025
8th Jul 20257:01 amRNSAppointment of CEO and Chair designate
8th Jul 20257:00 amRNSH1 Trading Update
9th May 20257:00 amRNSDirectorate Change
6th May 20253:00 pmRNSHolding(s) in Company
1st May 20253:12 pmRNSResult of AGM
30th Apr 20257:00 amRNSTrading Update
10th Apr 20254:02 pmRNSDirector/PDMR Shareholding
4th Apr 202511:10 amRNSDirector/PDMR Shareholding
1st Apr 20254:00 pmRNSHolding(s) in Company
28th Mar 20255:03 pmRNSDirector/PDMR Shareholding
28th Mar 20254:59 pmRNSDirector/PDMR Shareholding
24th Mar 202510:06 amRNSNotice of AGM
21st Mar 20254:44 pmRNSDirector/PDMR Shareholding
12th Mar 20259:06 amRNSDirector/PDMR Shareholding
12th Mar 20258:54 amRNSDirectorate Change
10th Mar 20258:32 amRNSDirector/PDMR Shareholding
5th Mar 202511:17 amRNSAnnual Financial Report
5th Mar 20257:00 amRNSFull year results for year ended 31 December 2024
4th Mar 202512:52 pmRNSHolding(s) in Company
19th Feb 20257:00 amRNSHolding(s) in Company
30th Jan 20255:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.